An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

In this section: For Health Professionals

COVID-19 Health Care Professional Resources

On This Page:

COVID-19 News for Health Care Professionals

COVID-19 Therapeutics

COVID-19 Vaccines

COVID-19 Tests

Personal Protective Equipment (PPE)

Two male and three female doctors wearing scrubs posing for the camera.

COVID-19 information from the FDA for health care professionals

COVID-19 News for Health Care Professionals

Vaccine News

FDA authorizes changes to simplify use of bivalent mRNA COVID-19 vaccines. (4/18/2023)
Bivalent Pfizer-BioNTech COVID-19 Vaccine authorized as booster dose for certain children 6 months through 4 years of age (3/14/2023)
Janssen COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) was revised to include a warning... (3/13/2023)
Updated (bivalent) COVID-19 vaccines authorized for children down to 6 months of age (12/8/2022)
Stakeholder Call: Updated COVID-19 Vaccine Boosters (9/2/2022)
More COVID-19 Vaccine News

Therapeutics News

FDA authorizes Gohibic (vilobelimab) injection for the treatment of COVID-19 (4/4/2023)
Evusheld is not currently authorized for emergency use in the U.S. (1/26/2023)
Shelf-Life Extension for Specific Lots of Paxlovid (1/18/2023)
FDA approved Actemra (tocilizumab) injection for treatment of COVID-19 in certain hospitalized adults (FAQs - PDF, 173 KB) (12/21/2022)
COVID-19 Therapeutics Expiration Dating Extensions

Testing News

FDA authorizes first over-the-counter at-home test to detect both influenza and COVID-19 viruses (2/24/2023)
Extended expiration dates for BinaxNOW, MaximBio ClearDetect, and iHealth COVID-19 tests (1/19/2023)
SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests (1/12/2023)
FDA revised the emergency use authorizations (EUAs) of all COVID-19 antigen tests: Repeat or serial testing (11/1/2022)
FDA updates COVID-19 test policy, encourages developers to seek traditional premarket review (9/27/2022)

Safety News

Medical Device Safety: Letters to Health Care Providers, Recalls, and Safety Communications
Safety Communications:
- Risk of Protection Failure with Certain O&M Halyard Surgical N95 Respirators, Surgical Masks, and Pediatric Face Masks (4/21/2023)
- Pulse Oximeter Accuracy and Limitations (9/15/2022)
Do Not Use Animal Products to Treat Humans:
- Ivermectin
- Chloroquine Phosphate
Consumers should not use: Hand Sanitizer List

Shortages

COVID-19 Emergency Use Authorizations (EUAs)

Vaccines
Drugs and Non-Vaccine Biological Products
- Spanish-language information (when available)
Medical Devices

COVID-19 Therapeutics

Questions? Contact the FDA’s Division of Drug Information at 301-796-3400 or druginfo@fda.hhs.gov. Learn more about reporting adverse events.

Antiviral Drugs

Veklury (remdesivir)
- Health Care Provider Information
- Health care Provider Preparation and Storage Information (PDF - 359 KB)
Paxlovid (nirmatrelvir co-packaged with ritonavir)
- Health Care Provider Fact Sheet
- Frequently Asked Questions
- Important Prescribing Information
- Prescriber Patient Eligibility Screening Checklist
- Dispensing Information for Patients with Moderate Renal Impairment
- Shelf-Life Extension for Specific Lots
Lagevrio (molnupiravir)
- Health Care Provider Fact Sheet
- Frequently Asked Questions
- Important Safety Information
- Checklist Tool for Prescribers

Immune Modulators

Actemra (tocilizumab)
- Health Care Provider Information - Biologic License Application (BLA): 125276 and 125472
- Health Care Provider EUA Fact Sheet
- Frequently Asked Questions
Baricitinib (olumiant)
- Health Care Provider Information
- Health Care Provider EUA Fact Sheet
- Frequently Asked Questions
Gohibic (vilobelimab)
- Health Care Provider Fact Sheet
- Frequently Asked Questions
Kineret (anakinra)
- Health Care Provider Fact Sheet
- Frequently Asked Questions

Convalescent Plasma

Health Care Provider Fact Sheet
Recommendations for Investigational COVID-19 Convalescent Plasma

Renal Replacement Therapies

Regiocit replacement solution
- Health Care Provider Fact Sheet
Fresenius Medical multiFiltrate/ multiBic/ multiPlus replacement solutions
- Health Care Provider Fact Sheet

COVID-19 Vaccines

FDA-Approved COVID-19 Vaccines

Comirnaty COVID-19 Vaccine
Spikevax COVID-19 Vaccine

FDA-Authorized COVID-19 Vaccines

Pfizer-BioNTech COVID-19 Vaccine, Bivalent
Moderna COVID-19 Vaccine, Bivalent
Novavax COVID-19 Vaccine, Adjuvanted
Janssen COVID-19 Vaccine

COVID-19 Vaccine Safety

Report a Vaccine Serious Adverse Event online
COVID-19 Vaccine Safety Surveillance
EUAs for COVID-19 Vaccines Explained

COVID-19 Tests

Test Authorizations

Molecular Diagnostic Tests with Emergency Use Authorization
Antigen Diagnostic Tests with Emergency Use Authorization
Serology and Other Adaptive Immune Response Tests with Emergency Use Authorization

Testing Information

At-Home OTC COVID-19 Diagnostic Tests
Understanding At-Home OTC COVID-19 Antigen Diagnostic Test Results
At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions (FAQs)
Take steps to reduce your risk of false negative at-home COVID-19 antigen tests.
FAQs on Testing for SARS-CoV-2
SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests

Personal Protective Equipment (PPE)

Top